K. Mcglynn and W. London, The Global Epidemiology of Hepatocellular Carcinoma: Present and Future, Clinics in Liver Disease, vol.15, issue.2, pp.223-243, 2011.
DOI : 10.1016/j.cld.2011.03.006

R. Li, N. Qian, K. Tao, N. You, X. Wang et al., MicroRNAs involved in neoplastic transformation of liver cancer stem cells, Journal of Experimental & Clinical Cancer Research, vol.29, issue.1, p.169, 2010.
DOI : 10.1186/1756-9966-29-169

Y. Begus-nahrmann, D. Hartmann, J. Kraus, P. Eshraghi, A. Scheffold et al., Transient telomere dysfunction induces chromosomal instability and promotes carcinogenesis, Journal of Clinical Investigation, vol.122, issue.6, pp.2283-2288, 2012.
DOI : 10.1172/JCI61745DS1
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3366409

P. Farazi, J. Glickman, J. Horner, and R. Depinho, Cooperative Interactions of p53 Mutation, Telomere Dysfunction, and Chronic Liver Damage in Hepatocellular Carcinoma Progression, Cancer Research, vol.66, issue.9, pp.4766-4773, 2006.
DOI : 10.1158/0008-5472.CAN-05-4608

P. Farazi, J. Glickman, S. Jiang, A. Yu, K. Rudolph et al., Differential impact of telomere dysfunction on initiation and progression of hepatocellular carcinoma, Cancer Res, vol.63, pp.5021-5027, 2003.

R. Plentz, M. Caselitz, J. Bleck, M. Gebel, P. Flemming et al., Hepatocellular telomere shortening correlates with chromosomal instability and the development of human hepatoma, Hepatology, vol.20, issue.1, pp.80-86, 2004.
DOI : 10.1002/hep.20271

R. Plentz, Y. Park, A. Lechel, H. Kim, F. Nellessen et al., Telomere shortening and inactivation of cell cycle checkpoints characterize human hepatocarcinogenesis, Hepatology, vol.39, issue.4, pp.968-976, 2007.
DOI : 10.1002/hep.21552

R. Plentz, B. Schlegelberger, P. Flemming, M. Gebel, H. Kreipe et al., Telomere shortening correlates with increasing aneuploidy of chromosome 8 in human hepatocellular carcinoma, Hepatology, vol.52, issue.3, pp.522-526, 2005.
DOI : 10.1002/hep.20847

X. Lai, C. Shen, Z. Wen, Y. Qian, C. Yu et al., PinX1 regulation of telomerase activity and apoptosis in nasopharyngeal carcinoma cells, Journal of Experimental & Clinical Cancer Research, vol.31, issue.1, p.12, 2012.
DOI : 10.1186/1756-9966-31-12

A. Bodnar, M. Ouellette, M. Frolkis, S. Holt, C. Chiu et al., Extension of Life-Span by Introduction of Telomerase into Normal Human Cells, Science, vol.279, issue.5349, pp.349-352, 1998.
DOI : 10.1126/science.279.5349.349

D. Lange and T. , Shelterin: the protein complex that shapes and safeguards human telomeres, Genes & Development, vol.19, issue.18, pp.2100-2110, 2005.
DOI : 10.1101/gad.1346005

E. Gilson and V. Geli, How telomeres are replicated, Nature Reviews Molecular Cell Biology, vol.66, issue.10, pp.825-838, 2007.
DOI : 10.1038/nrm2259

D. Fagagna, F. Reaper, P. Clay-farrace, L. Fiegler, H. Carr et al., A DNA damage checkpoint response in telomere-initiated senescence, Nature, vol.426, issue.6963, pp.194-198, 2003.
DOI : 10.1038/nature02118

L. Hayflick, The limited in vitro lifetime of human diploid cell strains, Experimental Cell Research, vol.37, issue.3, pp.614-636, 1965.
DOI : 10.1016/0014-4827(65)90211-9

L. Hayflick and P. Moorhead, The serial cultivation of human diploid cell strains, Experimental Cell Research, vol.25, issue.3, pp.585-621, 1961.
DOI : 10.1016/0014-4827(61)90192-6

J. Lukas, D. Parry, L. Aagaard, D. Mann, J. Bartkova et al., Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16, Nature, vol.375, issue.6531, pp.503-506, 1995.
DOI : 10.1038/375503a0

G. Stein, L. Drullinger, A. Soulard, and V. Dulic, Differential Roles for Cyclin-Dependent Kinase Inhibitors p21 and p16 in the Mechanisms of Senescence and Differentiation in Human Fibroblasts, Molecular and Cellular Biology, vol.19, issue.3, pp.2109-2117, 1999.
DOI : 10.1128/MCB.19.3.2109

H. Vaziri, M. West, R. Allsopp, T. Davison, Y. Wu et al., ATM-dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post-translational activation of p53 protein involving poly(ADP-ribose) polymerase. The EMBO journal, pp.6018-6033, 1997.

S. Artandi, S. Chang, S. Lee, S. Alson, G. Gottlieb et al., Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice, Nature, vol.406, pp.641-645, 2000.

S. Artandi and R. Depinho, A critical role for telomeres in suppressing and facilitating carcinogenesis, Current Opinion in Genetics & Development, vol.10, issue.1, pp.39-46, 2000.
DOI : 10.1016/S0959-437X(99)00047-7

K. Rudolph, M. Millard, M. Bosenberg, and R. Depinho, Telomere dysfunction and evolution of intestinal carcinoma in mice and humans, Nature Genetics, vol.28, issue.2, pp.155-159, 2001.
DOI : 10.1038/88871

I. Horikawa and J. Barrett, cis-Activation of the Human Telomerase Gene (hTERT) by the Hepatitis B Virus Genome, JNCI Journal of the National Cancer Institute, vol.93, issue.15, pp.1171-1173, 2001.
DOI : 10.1093/jnci/93.15.1171

H. Liu, W. Shi, F. Luan, S. Xu, F. Yang et al., Hepatitis B virus X protein upregulates transcriptional activation of human telomerase reverse transcriptase, Virus Genes, vol.16, issue.15, pp.174-182, 2010.
DOI : 10.1007/s11262-009-0441-3

Z. Qu, S. Zou, N. Cui, X. Wu, M. Qin et al., transfection of hepatitis B virus X gene into human hepatocarcinoma and cholangiocarcinoma cells, World Journal of Gastroenterology, vol.11, issue.36, pp.5627-5632, 2005.
DOI : 10.3748/wjg.v11.i36.5627

J. Su, X. Lai, K. Lan, C. Li, Y. Chao et al., X protein of hepatitis B virus functions as a transcriptional corepressor on the human telomerase promoter, Hepatology, vol.15, issue.2, pp.402-413, 2007.
DOI : 10.1002/hep.21675

X. Zhang, N. Dong, H. Zhang, J. You, H. Wang et al., Effects of hepatitis B virus X protein on human telomerase reverse transcriptase expression and activity in hepatoma cells, Journal of Laboratory and Clinical Medicine, vol.145, issue.2, pp.98-104, 2005.
DOI : 10.1016/j.lab.2004.11.018

S. Zou, Z. Qu, Z. Li, and X. Wang, Hepatitis B virus X gene induces human telomerase reverse transcriptase mRNA expression in cultured normal human cholangiocytes, World J Gastroenterol, vol.10, pp.2259-2262, 2004.

H. Liu, F. Luan, Y. Ju, H. Shen, L. Gao et al., In vitro transfection of the hepatitis B virus PreS2 gene into the human hepatocarcinoma cell line HepG2 induces upregulation of human telomerase reverse transcriptase, Biochemical and Biophysical Research Communications, vol.355, issue.2, pp.379-384, 2007.
DOI : 10.1016/j.bbrc.2007.01.160

F. Luan, H. Liu, L. Gao, J. Liu, Z. Sun et al., Hepatitis B virus protein preS2 potentially promotes HCC development via its transcriptional activation of hTERT, Gut, vol.58, issue.11, pp.1528-1537, 2009.
DOI : 10.1136/gut.2008.174029

Z. Zhu, A. Wilson, K. Gopalakrishna, K. Brown, B. Luxon et al., Hepatitis C virus core protein enhances Telomerase activity in Huh7 cells, Journal of Medical Virology, vol.48, issue.2, pp.239-248, 2010.
DOI : 10.1002/jmv.21644

S. Pavanello, M. Hoxha, L. Dioni, P. Bertazzi, R. Snenghi et al., Shortened telomeres in individuals with abuse in alcohol consumption, International Journal of Cancer, vol.20, issue.4, pp.983-992, 2011.
DOI : 10.1002/ijc.25999

M. Pfaffl, A. Tichopad, C. Prgomet, and T. Neuvians, Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper ??? Excel-based tool using pair-wise correlations, Biotechnology Letters, vol.26, issue.6, pp.509-515, 2004.
DOI : 10.1023/B:BILE.0000019559.84305.47

K. Livak and T. Schmittgen, Analysis of relative gene expression data using real-time quantitative PCR and the 2(?Delta Delta C(T)) Method, pp.402-408, 2001.

N. Saini, R. Srinivasan, Y. Chawla, S. Sharma, A. Chakraborti et al., Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status, Liver International, vol.29, issue.8, pp.1162-1170, 2009.
DOI : 10.1111/j.1478-3231.2009.02082.x

Y. Guo, X. Zhou, E. Liu, X. Li, J. Liu et al., Difference in hTERT gene expressions between HbsAg-positive and HbsAg-negative hepatocellular carcinoma, J Huazhong Univ Sci Technolog Med Sci, vol.25, pp.303-306, 2005.

B. Oh, Y. Kim, C. Park, and Y. Park, Up-Regulation of Telomere-Binding Proteins, TRF1, TRF2, and TIN2 Is Related to Telomere Shortening during Human Multistep Hepatocarcinogenesis, The American Journal of Pathology, vol.166, issue.1, pp.73-80, 2005.
DOI : 10.1016/S0002-9440(10)62233-X

L. Denchi, E. Celli, G. , D. Lange, and T. , Hepatocytes with extensive telomere deprotection and fusion remain viable and regenerate liver mass through endoreduplication, Genes & Development, vol.20, issue.19, pp.2648-2653, 2006.
DOI : 10.1101/gad.1453606

Y. Hu, Y. Shen, J. B. Wang, L. Zhang, Z. Zhang et al., Combinational RNAi gene therapy of hepatocellular carcinoma by targeting human EGFR and TERT, European Journal of Pharmaceutical Sciences, vol.42, issue.4, pp.387-391, 2011.
DOI : 10.1016/j.ejps.2011.01.004

T. Greten, A. Forner, F. Korangy, N. Kontchou, G. Barget et al., A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinoma, BMC Cancer, vol.8, issue.2, p.209, 2010.
DOI : 10.1158/1535-7163.MCT-08-1051

X. Guo, W. Wang, F. Zhou, Z. Lu, R. Fang et al., siRNA-mediated inhibition of hTERT enhances chemosensitivity of hepatocellular carcinoma, Cancer Biology & Therapy, vol.7, issue.10, pp.1555-1560, 2008.
DOI : 10.4161/cbt.7.10.6539